Plunkett Research Online: Eastwood Bio-Medical

EASTWOOD BIO-MEDICAL (EBM:TSX) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Eastwood Bio-Medical Canada Inc is engaged in the development and commercialization of safe and effective treatment for non-insulin dependent diabetes mellitus. The Company distributes Eleotin products and related products in North America......



Eastwood Bio-Medical
Ticker: EBM
Exchange: TSX
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 604 247-2100
Fax:
Address: Unit 1130-4871 Shell Road
Richmond, BC V6X 3Z6 Canada

Types Of Business
Industry Ranks

Industry NAICS code:

Medical, Dental and Hospital Equipment and Supplies (Medical Devices) Wholesale Distribution
ContactsDescription
Peter ChenCFO/Director
Marcus KuypersDirector
See More
Eastwood Bio-Medical Canada Inc is engaged in the development and commercialization of safe and effective treatment for non-insulin dependent diabetes mellitus. The Company distributes Eleotin products and related products in North America......See More See More

Auditor:
Legal Advisor:
$USD, In whole numbers,
except marked * or %
2016201520142013
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: